PPA
PACB icon

Parametric Portfolio Associates’s Pacific Biosciences PACB Stock Holding History

Parametric Portfolio Associates’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.32M Buy
144,751
+21,010
+17% +$242K ﹤0.01% 2649
2021
Q4 		$2.53M Sell
123,741
-2,417
-2% -$58.3K ﹤0.01% 2300
2021
Q3 		$3.22M Sell
126,158
-12,536
-9% -$371K ﹤0.01% 2134
2021
Q2 		$4.85M Sell
138,694
-27,186
-16% -$791K ﹤0.01% 1871
2021
Q1 		$5.53M Buy
165,880
+55,369
+50% +$1.94M ﹤0.01% 2093
2020
Q4 		$2.87M Buy
110,511
+9,995
+10% +$170K ﹤0.01% 2431
2020
Q3 		$992K Buy
100,516
+9,100
+10% +$52.4K ﹤0.01% 2923
2020
Q2 		$315K Sell
91,416
-118,560
-56% -$404K ﹤0.01% 3454
2020
Q1 		$643K Sell
209,976
-40,323
-16% -$165K ﹤0.01% 3026
2019
Q4 		$1.29M Sell
250,299
-15,299
-6% -$77.8K ﹤0.01% 2925
2019
Q3 		$1.37M Buy
265,598
+22,401
+9% +$125K ﹤0.01% 2857
2019
Q2 		$1.47M Buy
243,197
+52,352
+27% +$367K ﹤0.01% 2846
2019
Q1 		$1.38M Sell
190,845
-53,337
-22% -$386K ﹤0.01% 2866
2018
Q4 		$1.81M Sell
244,182
-22,329
-8% -$141K ﹤0.01% 2647
2018
Q3 		$1.44M Sell
266,511
-83,580
-24% -$359K ﹤0.01% 2909
2018
Q2 		$1.24M Buy
350,091
+39,560
+13% +$110K ﹤0.01% 2944
2018
Q1 		$637K Buy
310,531
+66,550
+27% +$173K ﹤0.01% 3231
2017
Q4 		$644K Buy
243,981
+71,864
+42% +$252K ﹤0.01% 3212
2017
Q3 		$904K Buy
172,117
+26,280
+18% +$113K ﹤0.01% 3094
2017
Q2 		$519K Sell
145,837
-38,918
-21% -$157K ﹤0.01% 3350
2017
Q1 		$955K Buy
184,755
+65,899
+55% +$323K ﹤0.01% 2881
2016
Q4 		$452K Sell
118,856
-12,166
-9% -$88.4K ﹤0.01% 3237
2016
Q3 		$1.17M Sell
131,022
-27,121
-17% -$227K ﹤0.01% 2709
2016
Q2 		$1.11M Buy
158,143
+50,389
+47% +$460K ﹤0.01% 2740
2016
Q1 		$916K Buy
107,754
+24,768
+30% +$244K ﹤0.01% 2985
2015
Q4 		$1.09M Sell
82,986
-4,528
-5% -$40.6K ﹤0.01% 2709
2015
Q3 		$320K Sell
87,514
-2,131
-2% -$10.4K ﹤0.01% 2928
2015
Q2 		$516K Buy
89,645
+2,641
+3% +$15.3K ﹤0.01% 3262
2015
Q1 		$508K Sell
87,004
-41,894
-33% -$289K ﹤0.01% 3249
2014
Q4 		$1.01M Sell
128,898
-100,014
-44% -$640K ﹤0.01% 2778
2014
Q3 		$1.12M Sell
228,912
-20,614
-8% -$108K ﹤0.01% 2596
2014
Q2 		$1.54M Sell
249,526
-2,328
-0.9% -$11.7K ﹤0.01% 2344
2014
Q1 		$1.35M Buy
251,854
+42,950
+21% +$271K ﹤0.01% 2407
2013
Q4 		$1.09M Buy
208,904
+107,309
+106% +$493K ﹤0.01% 2581
2013
Q3 		$561K Buy
101,595
+4,454
+5% +$15.5K ﹤0.01% 3020
2013
Q2 		$246K Buy
+97,141
New +$242K ﹤0.01% 3373

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Parametric Portfolio Associates's PACB Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Pacific Biosciences (PACB) stake by 17% in Q1 2022, buying an estimated $242K and bringing the position to 144,751 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Parametric Portfolio Associates first reported a position in PACB in Q2 2013 and has held it in 36 quarters since. The position peaked at $5.53M in Q1 2021. 250 funds tracked by Wall St. Rank hold PACB as of Q1 2022.

  • Parametric Portfolio Associates held 144,751 shares of Pacific Biosciences worth $1.32M as of Q1 2022.
  • Parametric Portfolio Associates bought 21,010 Pacific Biosciences shares in Q1 2022, an estimated $242K.
  • Pacific Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2649 holding.
  • Parametric Portfolio Associates first reported a position in Pacific Biosciences in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Pacific Biosciences position peaked at $5.53M in Q1 2021.
  • 250 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.